TReatment by Insulin Continuous Infusion in Type 2 DIAbetes
Status:
Unknown status
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The aim of the TRICIDIA2 study is to compare two modalities of administration of insulin.
In our future study, the investigators wish to study if the treatment by continuous infusion
of insulin improves the insulinosensitivity of type 2 diabetic patients; the investigators
indeed expect that the insulin delivered in a continuous way decreases the
insulino-resistance of these patients compared with the intermittent delivering of insulin.